iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Recruiting · NCT03549754 · Observational (researchers observe without assigning treatment) · Lead sponsor: AstraZeneca
View the official record on ClinicalTrials.gov →What this trial is about
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Being 18 years or older
- Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
- Providing written informed consent to participate in the registry
Exclusion criteria
- Having a life-threatening co-morbidity with life expectancy below 1 year
- Participating in an interventional trial requiring informed consent
Where it is running
60 locations listed.
- Research Site - Abidjan, Côte d’Ivoire
- Research Site - Ahmedabad, India
- Research Site - Aktobe, Kazakhstan
- Research Site - Alexandria, Egypt
- Research Site - Almaty, Kazakhstan
- Research Site - Almaty, Kazakhstan
- Research Site - Almaty, Kazakhstan
- Research Site - Almaty, Kazakhstan
- Research Site - Bulacan, Philippines
- Research Site - Cairo, Egypt
- Research Site - Cebu City, Philippines
- Research Site - Changhua, Taiwan
- Research Site - Enugu, Nigeria
- Research Site - Florida, South Africa
- Research Site - Giza, Egypt
- Research Site - Gwagwalada, Nigeria
- Research Site - Iloilo City, Philippines
- Research Site - Iztapalapa, Mexico
- Research Site - Kano, Nigeria
- Research Site - Kaohsiung City, Taiwan
- Research Site - Kolkata, India
- Research Site - Kuala Lumpur, Malaysia
- Research Site - Kumasi, Ghana
- Research Site - Laguna, Philippines
- Research Site - Mandaluyong, Philippines
- Research Site - Manila, Philippines
- Research Site - Mexico City, Mexico
- Research Site - Mexico City, Mexico
- Research Site - Mindoro, Philippines
- Research Site - Mumbai, India
- Research Site - México, Mexico
- Research Site - Nairobi, Kenya
- Research Site - Niaosong, Taiwan
- Research Site - Pampanga, Philippines
- Research Site - Parow, South Africa
- Research Site - Quezon City, Philippines
- Research Site - San José, Costa Rica
- Research Site - Sharjah city, United Arab Emirates
- Research Site - Sulaymaniyah, Iraq
- Research Site - São Paulo, Brazil
- Research Site - São Paulo, Brazil
- Research Site - Taichung, Taiwan
- Research Site - Taichung, Taiwan
- Research Site - Taichung, Taiwan
- Research Site - Tainan, Taiwan
- Research Site - Taipei, Taiwan
- Research Site - Taoyuan City, Taiwan
- Research Site - Tbilisi, Georgia
- Research Site - Umhlanga, South Africa
- Research Site - Umhlanga, South Africa
- Research Site - Wan Chai, Hong Kong
- Research Site - Zamboanga City, Philippines
- Research Site - Fortaleza, Ceará, Brazil
- Research Site - Dnipro, Dnipropetrovsk Oblast, Ukraine
- Research Site - Colatina, Espírito Santo (ES), Brazil
- Research Site - Salvador, Estado de Bahia, Brazil
- Research Site - Brasília, Federal District, Brazil
- Research Site - León, Guanajuato, Mexico
- Research Site - Kharkiv, Kharkiv Oblast, Ukraine
- Research Site - Kharkiv, Kharkiv Oblast, Ukraine
Showing 60 of 76 listed sites. See the official record for the complete list.
Read the full protocol, contacts and eligibility on ClinicalTrials.gov →